Large Independent Randomized Controlled Trial Validates MolecuLight’s Transformative Impact on Wound Debridement, Showing Improved Outcomes and Lower Costs

August 27, 2025 -

TORONTO, ON and TAIPEI, TAIWAN, August 27, 2025 – MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for wound care, together with its Taiwanese distributor, Healtdeva Company Ltd., today announced the publication of the largest-ever randomized controlled trial (RCT) on its technology. Independently conducted and published

MolecuLight “Lights the Way to Equitable Wound Care” at National Medical Association Conference

July 18, 2025 -

Pittsburgh, USA – July 18, 2025 – MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for wound care, today announced its participation in the National Medical Association (NMA) Annual Convention and Scientific Assembly, being held from July 19-23, 2025, in Chicago, IL. Attendees are invited to

MolecuLight Appoints Dr. Julia Wright as Chief Medical Officer to Accelerate Clinical Adoption

July 10, 2025 -

TORONTO, CANADA – July 10, 2025 – MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for wound care, today announced the appointment of Dr. Julia Wright, MD, FACP, as its new Chief Medical Officer (CMO). Dr. Wright, an exceptionally respected physician with a distinguished 25-year career

Landmark Study Affirms MolecuLight’s Efficacy in Real-Time Bacterial Detection for Improved Wound Management

June 26, 2025 -

TORONTO, CANADA – June 26, 2025 – MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for wound care, proudly announces the publication of a landmark systematic review by researchers at Trinity College Dublin and the Royal College of Surgeons in Ireland (RCSI). Titled “The Clinical Utility

MolecuLight® Imaging Significantly Improves Outcomes and Cuts Costs for Deep Sternal Wound Infections in Taiwan Study; Signals Expansion into Surgical Applications

June 12, 2025 -

Toronto, CANADA and Taipei, TAIWAN – June 12, 2025 – MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for wound care, and its Taiwanese distributor, Healtdeva Company Ltd., congratulate researchers at Shuang-Ho Hospital in Taipei, Taiwan on their publication of groundbreaking findings using MolecuLight. The

MolecuLight to Showcase Innovative Wound Imaging Platform at the Society for Vascular Surgery Vascular Annual Meeting (VAM) 2025

June 4, 2025 -

Toronto, Canada – June 4, 2025 – MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, is pleased to announce its participation in the Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM), taking place in New Orleans,

MolecuLight Unveils Thermal Imaging for DX™ Platform, Delivering Measurement, Bacterial & Thermal Assessment in One Device, and Showcases Clinical Evidence at SAWC Spring

April 30, 2025 -

Toronto, Canada – April 30, 2025 – MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, today announced the immediate availability of its new Thermal Imaging Module for the MolecuLightDX™ fluorescence imaging platform. This innovative clip-on module allows

MolecuLight and DocNow Announce Integration for Seamless Data and Image Transfer for DX Devices

April 29, 2025 -

Toronto, Canada – April 29, 2025 – MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, and DocNow, an innovative post-acute Electronic Health Record (EHR) platform, today announced their integration for the MolecuLightDX™ device.

This powerful collaboration will

MolecuLight Optimizes Burn Care with Advanced Bacterial Imaging at the American Burn Association 2025 Annual Meeting

April 8, 2025 -

Toronto, Canada – April 8th, 2025 – MolecuLight, a global pioneer in point-of-care fluorescence imaging for rapid bacterial detection in wounds, announces its presence at the American Burn Association (ABA) Annual Meeting in Phoenix, AZ, April 8-11. MolecuLight will showcase its innovative fluorescence imaging systems that empower